Showing results (131-140 of 191) with videos related to

Sort By:
Pageof 20
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 3, 2008
Evidence why paroxetine dose escalation is not effective in major depressive disorder: a randomized controlled trial with assessment of serotonin transporter occupancyHenricus G Ruhé, Jan Booij, Henk C v Weert, et al.
European Addiction Research|June 30, 2021
Barriers and Facilitators to Seek Help for Substance Use Disorder among Dutch Physicians: A Qualitative StudyPauline M Geuijen, Esther Pars, Joanneke M Kuppens, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 10, 2015
Deviant white matter structure in adults with attention-deficit/hyperactivity disorder points to aberrant myelination and affects neuropsychological performanceA Marten H Onnink, Marcel P Zwiers, Martine Hoogman, et al.
The Journal of Clinical Endocrinology and Metabolism|December 8, 2004
Triiodothyronine addition to paroxetine in the treatment of major depressive disorderBente C Appelhof, Jantien P Brouwer, Richard van Dyck, et al.
Journal of Affective Disorders|August 29, 2016
The Dutch Measure for quantification of Treatment Resistance in Depression (DM-TRD): an extension of the Maudsley Staging MethodFrenk P M L Peeters, Henricus G Ruhe, Marieke Wichers, et al.
European Heart Journal|September 7, 2005
Relationship between left ventricular dysfunction and depression following myocardial infarction: data from the MIND-ITJoost P van Melle, Peter de Jonge, Johan Ormel, et al.
Pageof 20